Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LENZ Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 4.73K | $9.85K | $2.08 | Apr 9, 2025 | Direct |
LENZ Therapeutics, Inc. | Chief Commercial Officer | Stock Option (right to buy) | 63.2K | Apr 9, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LENZ | LENZ Therapeutics, Inc. | Apr 9, 2025 | 2 | $2.91K | 4 | Apr 9, 2025 | Chief Commercial Officer |
LENZ | LENZ Therapeutics, Inc. | Jan 9, 2025 | 1 | $0 | 4 | Jan 13, 2025 | Chief Commercial Officer |
LENZ | LENZ Therapeutics, Inc. | Dec 16, 2024 | 2 | $6.93K | 4 | Dec 17, 2024 | Chief Commercial Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 4 | $0 | 4 | Mar 25, 2024 | Chief Commercial Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Chief Commercial Officer |